INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 179 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,979,000 | -64.9% | 56,915 | -75.0% | 0.17% | -65.3% |
| Q3 2021 | $8,478,000 | -33.7% | 227,419 | -27.4% | 0.50% | -31.9% |
| Q2 2021 | $12,783,000 | -42.5% | 313,159 | -52.2% | 0.74% | -44.8% |
| Q1 2021 | $22,224,000 | -17.6% | 655,001 | -22.8% | 1.34% | -16.8% |
| Q4 2020 | $26,972,000 | +108.7% | 848,162 | +68.4% | 1.61% | +67.6% |
| Q3 2020 | $12,921,000 | +108.1% | 503,555 | +108.2% | 0.96% | +145.0% |
| Q2 2020 | $6,209,000 | +676.1% | 241,908 | +365.2% | 0.39% | +428.4% |
| Q1 2020 | $800,000 | -51.1% | 52,005 | -58.7% | 0.07% | -50.7% |
| Q2 2019 | $1,635,000 | – | 125,955 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |